Home ›
Trademark Categories ›
Pharmaceuticals ›
2015 ›
EB ›
EBRIMOZ
Trademark search for:
EBRIMOZ
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2015-02-05 — Application filed
2015-02-09 — Application filed
2015-02-18 — Application filed
2015-02-24 — Assigned to examiner
2015-02-27 — Priority action written
2015-02-27 — Priority action e-mailed
2015-02-27 — Notification of priority action e-mailed
2015-08-25 — Approved for pub - principal register
2015-08-25 — Teas/email correspondence entered
2015-08-25 — Office action issued
2015-08-25 — Correspondence received in law office
2015-09-21 — Assigned to lie
2015-10-03 — Law office publication review completed
2015-10-21 — Notification of notice of publication e-mailed
2015-11-10 — Published for opposition
2015-11-10 — Official gazette publication confirmation e-mailed
2016-01-05 — Noa e-mailed - sou required from applicant
2016-07-02 — Sou teas extension received
2016-07-02 — Sou extension 1 filed
2016-07-02 — Sou extension 1 granted
2016-07-05 — Notice of approval of extension request e-mailed
2017-01-02 — Sou teas extension received
2017-01-02 — Sou extension 2 filed
2017-01-02 — Sou extension 2 granted
2017-01-04 — Notice of approval of extension request e-mailed
2017-06-29 — Sou teas extension received
2017-06-29 — Sou extension 3 filed
2017-06-29 — Sou extension 3 granted
2017-07-01 — Notice of approval of extension request e-mailed
2018-01-02 — Sou teas extension received
2018-01-02 — Sou extension 4 granted
2018-01-02 — Sou extension 4 filed
2018-01-04 — Notice of approval of extension request e-mailed
2018-06-29 — Sou teas extension received
2018-06-29 — Sou extension 5 filed
2018-07-05 — Case assigned to intent to use paralegal
2018-07-05 — Sou extension 5 granted
2018-07-06 — Notice of approval of extension request e-mailed
2019-02-11 — Application abandoned
2019-02-11 — Application abandoned
2019-02-11 — Final status recorded
Owner Information
Novartis AG
Basel CH
Novartis AG
Basel CH
Correspondent
MAURY M. TEPPER, III Tepper & Eyster Pllc 3724 Benson Dr Raleigh, NC 27609-7321 UNITED STATES
Filing Details
Filing Date:
2015-02-05
Status Date:
2019-02-11
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.